- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00717444
Healthy Activities for Prize Incentives (HAPI)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06106
- Connections, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- HIV+ and a member of Connections
- Age 18-65 years
- English speaking
- Past-year DSM-IV diagnosis of opioid, cocaine, methamphetamine, alcohol, or marijuana abuse or dependence
- Written permission from one's primary care or infectious disease physician to participate in the study and an exercise program
- Plans to reside in the local area for the next 8 months and
- Willing to sign informed consent
Exclusion Criteria:
- Inability to comprehend the study as assessed by the Informed Consent Quiz and Mini-Mental Status Exam (MMSE)
- Severely disruptive behavior
- In recovery for pathological gambling (due to potential similarity between the contingency management procedure and gambling)
- Serious uncontrolled psychiatric disorder other than substance use disorders that require inpatient hospitalization (e.g., active bipolar disorder, psychosis, suicidal)
- History of myocardial infarction, stroke, unstable angina, coronary artery bypass grafting, angioplasty/stent, uncontrolled arrhythmia, or hyperthyroidism in the past 6 months as reported by patient or physician
- Blood pressure >165/95 mmHg and
- Grossly abnormal findings on indices of physical functioning (>2 SDs above means for sedentary age/gender norms according to ACSM, 2006)
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
contingency management for abstinence plus 12-step facilitation therapy and contingency management for completing healthy activities
|
contingency management for abstinence plus 12-step facilitation therapy prizes awarded for target behaviors contingency management for abstinence plus 12-step facilitation therapy and contingency management for completing healthy activities prizes awarded for target behaviors |
Experimental: 2
contingency management for abstinence plus 12-step facilitation therapy
|
contingency management for abstinence plus 12-step facilitation therapy prizes awarded for target behaviors contingency management for abstinence plus 12-step facilitation therapy and contingency management for completing healthy activities prizes awarded for target behaviors |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
drug use
Time Frame: baseline and each follow-up
|
baseline and each follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
physical activity
Time Frame: baseline and each follow-up
|
baseline and each follow-up
|
psychological symptoms
Time Frame: baseline and each follow-up
|
baseline and each follow-up
|
medical outcomes
Time Frame: baseline and each follow-up
|
baseline and each follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nancy M Petry, Ph.D., UConn Health
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-251-2
- 1R01DA022739-01A2 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on contingency management
-
VA Office of Research and DevelopmentRecruitingPTSD | Cannabis-Related DisorderUnited States
-
Johns Hopkins UniversityJohns Hopkins Community PhysiciansWithdrawnSubstance-related DisorderUnited States
-
University of California, Los AngelesCompleted
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
UConn HealthNational Institute on Drug Abuse (NIDA)CompletedContingency Management | Exercise | Substance AbuseUnited States
-
Washington State UniversityCompleted
-
The University of Texas Health Science Center at...National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Douglas Mental Health University InstituteRecruitingPsychotic Disorders | Cognitive Dysfunction | Cannabis Dependence | Cannabis Use | Memory Impairment | Schizophrenia; Psychosis | Cannabis Use Disorder | NeuroimagingCanada
-
University of Colorado, DenverUniversity of Colorado, BoulderEnrolling by invitation